Nonmodal Clinical Decision Support and Antimicrobial Restriction Effects on Rates of Fluoroquinolone Use in Uncomplicated Infections
26 August 2017
31 December 2017
28 February 2018 (online)
Background Medication alert overrides remain persistently high over the past decade, influenced by factors such as “alert fatigue” and lack of provider acceptance.
Objective We compared the aggregate rate of fluoroquinolone (FQ) prescribing for the treatment of acute sinusitis, acute bronchitis, and uncomplicated urinary tract infections (UTIs) in adult inpatients prior to (historical control group) and after (prospective intervention group) implementation of a program requiring indication when ordering FQ antibiotics in combination with a nonmodal best-practice alert regarding the latest U.S. Food and Drug Administration (FDA) recommendations. We then compared rates of prescribing among provider type, severity of infection, and patient age.
Methods Qualified orders were defined as new FQ orders for acute sinusitis, acute bronchitis, and uncomplicated UTI for adult inpatients between July 2016 through September 2016 (control) or November 2016 through January 2017 (intervention). The primary endpoint was a provider-initiated FQ order for a target indication. Secondary endpoints included FQ orders by provider type and patient age. Rates of FQ use among the target indications were compared between groups by chi-square test of independence with Yates' correction in the analysis of the primary endpoint and Fisher's exact test for secondary endpoints.
Results FQ prescribing for acute bronchitis, and uncomplicated UTI occurred at a rate of 86/350 (24.6%) and 62/394 (15.7%) in the control and experimental groups, respectively (p = 0.0035). No patients receiving FQ qualified for a diagnosis of acute sinusitis.
Conclusion A program combining FQ restriction in combination with nonmodal messaging may have decreased the rate of prescribing for acute bronchitis and uncomplicated UTI, although the contributions of each individual element could not be rigorously assessed.
Protection of Human and Animal Subjects
Human and/or animal subjects were not included in this project, which was reviewed by Cape Fear Valley Health System Institutional Review Board.
- 1 CMS. Home - Centers for Medicare & Medicaid Services. Centers for Medicare & Medicaid Services; 2017. Available at: http://www.cms.gov/ . Accessed June 19, 2017
- 2 Bryant AD, Fletcher GS, Payne TH. Drug interaction alert override rates in the Meaningful Use era: no evidence of progress. Appl Clin Inform 2014; 5 (03) 802-813
- 3 van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13 (02) 138-147
- 4 Forrest GN, Van Schooneveld TC, Kullar R, Schulz LT, Duong P, Postelnick M. Use of electronic health records and clinical decision support systems for antimicrobial stewardship. Clin Infect Dis 2014; 59 (Suppl. 03) S122-S133
- 5 Saverno KR, Hines LE, Warholak TL. , et al. Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions. J Am Med Inform Assoc 2011; 18 (01) 32-37
- 6 Hsieh TC, Kuperman GJ, Jaggi T. , et al. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system. J Am Med Inform Assoc 2004; 11 (06) 482-491
- 7 Schulz L, Osterby K, Fox B. The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record. Infect Control Hosp Epidemiol 2013; 34 (12) 1259-1265
- 8 Roshanov PS, Fernandes N, Wilczynski JM. , et al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 2013; 346: f657 . Doi: 10.1136/bmj.f657
- 9 Boel J, Andreasen V, Jarløv JO. , et al. Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother 2016; 71 (07) 2047-2051
- 10 Shea KM, Hobbs ALV, Jaso TC. , et al. Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of clostridium difficile infection. Antimicrob Agents Chemother 2017; 61 (06) e00125-17
- 11 Richardson LP, Wiseman SW, Malani PN, Lyons MJ, Kauffman CA. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff. Microb Drug Resist 2000; 6 (04) 327-330
- 12 Davey P, Marwick CA, Scott CL. , et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017; 2: CD003543
- 13 U.S. Food and Drug Administration Home Page. FDA Drug Safety Communication. U.S. Food and Drug Administration. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM500591.pdf . Accessed June 19, 2017
- 14 Gupta K, Hooton TM, Naber KG. , et al; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52 (05) e103-e120
- 15 Centers for Disease Control and Prevention. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2014. . Available at: http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html . Accessed March 1, 2017
- 16 Scott GPT, Shah P, Wyatt JC, Makubate B, Cross FW. Making electronic prescribing alerts more effective: scenario-based experimental study in junior doctors. J Am Med Inform Assoc 2011; 18 (06) 789-798
- 17 Wipfli R, Betrancourt M, Guardia A, Lovis C. A qualitative analysis of prescription activity and alert usage in a computerized physician order entry system. Stud Health Technol Inform 2011; 169: 940-944